ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024
Correction to "FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.